J Exp Clin Cancer Res. 2006 Jun;25(2):201-6.

Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I study.

Burgdorf SK, Fischer A, Claesson MH, Kirkin AF, Dzhandzhugazyan KN, Rosenberg J.

Source

Department of Surgical Gastroenterology, University Hospital of Copenhagen, Denmark. stebur01@gentoftehosp.kbhamt.dk

Abstract

Immune therapy have shown new and exciting perspectives for cancer treatment. Aim of our study was to evaluate toxicity and possible adverse effects from vaccination of patients with advanced colorectal cancer with autologous dendritic cells (DC) pulsed with lysate from a newly developed melanoma cell line, DDM-1.13. Six patients were enrolled in the phase I trial. Autologous DCs were generated in vitro from peripheral blood monocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). DCs were pulsed with melanoma cell lysate from a cloned and selected melanoma cell line enriched in expression of MAGE-A antigens and deficient in expression of melanoma differentiation antigens: tyrosinase, MART-1 and gp100. Vaccinations were administered intradermally on the proximal thigh with a total of five given vaccines at 2 weeks intervals. Each vaccine contained 3-5 x 10(6) DCs. Five of the six patients received all five vaccines. The treatment was well tolerated in all patients without any observed vaccine-correlated adverse effects. Treatment with this DC-based cancer vaccine proved safe and non-toxic.

PMID:: 16918131; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Swets Information Services

Medical

Supplemental Content

Save items

Related citations in PubMed

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. [J Clin Oncol. 2003]
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Slingluff CL Jr, Petroni GR, Yamshchikov GV, Barnd DL, Eastham S, Galavotti H, Patterson JW, Deacon DH, Hibbitts S, Teates D, et al. J Clin Oncol. 2003 Nov 1; 21(21):4016-26.
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100. [J Immunother. 2000]
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100.
Panelli MC, Wunderlich J, Jeffries J, Wang E, Mixon A, Rosenberg SA, Marincola FM. J Immunother. 2000 Jul-Aug; 23(4):487-98.
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate. [Cancer Immunol Immunother. 2006]
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M, Bercovici N, Taylor R, Vereecken P, Massicard S, Duriau D, Vernel-Pauillac F, Boyer A, Baron-Bodo V, Mallard E, et al. Cancer Immunol Immunother. 2006 Jul; 55(7):819-29. Epub 2005 Sep 27.
Review Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice. [J Surg Oncol. 1998]
Review Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice.
DeMatos P, Abdel-Wahab Z, Vervaert C, Hester D, Seigler H. J Surg Oncol. 1998 Jun; 68(2):79-91.
Review Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives. [Hum Cell. 2003]
Review Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.
Morisaki T, Matsumoto K, Onishi H, Kuroki H, Baba E, Tasaki A, Kubo M, Nakamura M, Inaba S, Yamaguchi K, et al. Hum Cell. 2003 Dec; 16(4):175-82.

See reviews... See all...

Cited by 2 PubMed Central articles

Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine. [Cancer Immun. 2009]
Real-time PCR analysis of genes encoding tumor antigens in esophageal tumors and a cancer vaccine.
Weinert BT, Krishnadath KK, Milano F, Pedersen AW, Claesson MH, Zocca MB. Cancer Immun. 2009 Oct 9; 9:9. Epub 2009 Oct 9.
Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy. [Am J Pathol. 2009]
Epigenetic modulation of cancer-germline antigen gene expression in tumorigenic human mesenchymal stem cells: implications for cancer therapy.
Gjerstorff M, Burns JS, Nielsen O, Kassem M, Ditzel H. Am J Pathol. 2009 Jul; 175(1):314-23. Epub 2009 Jun 4.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanc...
Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I study.
J Exp Clin Cancer Res. 2006 Jun ;25(2):201-6.

PubMed
Effect of resveratrol on proliferation and telomerase activity of human colon ca...
Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro.
J Exp Clin Cancer Res. 2006 Jun ;25(2):189-93.

PubMed
Metabolic endophenotype and related genotypes are associated with oxidative stre...
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism.
Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5 ;141B(8):947-56.

PubMed
On the pathogenesis of duchenne muscular dystrophy.
On the pathogenesis of duchenne muscular dystrophy.
Dev Med Child Neurol. 1975 Aug ;17(4):527-33.

PubMed
Diagnostic yield of various genetic approaches in patients with unexplained deve...
Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation.
Am J Med Genet A. 2006 Oct 1 ;140(19):2063-74.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Vaccination with melanoma lysate-pulsed dendritic cells, of patients with advanced colorectal carcinoma: report from a phase I study.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information